APA. A. Prishchepov

A. A. Prishchepov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. A. Prishchepov has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Atypical case of glioblastoma localization: infratentorial localization (Clinical Case and the Review of the Literature)

    by R. S. Talybov, T. N. Trofimova, V. I. Pavlova, I. V. Shvetsov, V. V. Mochalov, M. E. Martirosyan, A. A. Prishchepov

    Glioblastoma is the most common high-grade primary brain tumor, occurring primarily in adults. This infiltrating tumor locates deep in the white matter, subcortical structures and thalamus. The typical localization of glioblastoma is supratentorial, accounting for more than 99% of cases. Primary infratentorial growth of glioblastomas involving the cerebellum is a very rare condition, occurring in less than 1 % of cases reported in the literature. The differential diagnosis consists mainly of solitary metastatic lesions and medulloblastoma. The clinical manifestations of cerebellar lesions are similar, but the methods of surgical and chemoradiotherapy treatment, prognosis and outcome in cases with various histologic types of the tumors are different.Thus radiology, carried out using multiparametric MRI mapping, is an decision making procedure. In thus publication we present an atypical case of infratentorial glioblastoma in a 45-yearold patient.


  • Open Access

    Sporadic malignant melanotic nerve sheath tumor: rare clinical case

    by D. A. Murzaeva, N. A. Mashkina, E. N. Samoilova, A. A. Prishchepov, A. V. Simonov, Y. M. Zabrodskaya, Ю. М. Забродская

    . Malignant melanotic nerve sheath tumor is rare disease which is characterized by aggressive clinical course. In classification of tumors CNS WHO 2021 has been changed its position from benign to malignant nerve tumors, however, there are not guidelines for treatment such patients.CASE REPORT. We present a rare case of MM NST in a 36-year-old woman with a paravertebral tumor of Th4-Th6 vertebrae, without metastases, mitosis, necrosis, invasive growth, with low proliferative activity, also presence of capsule, cystic component, growth from nerve — these features help distinguish from melanoma.CONCLUSION. The clinical case of a rare nerve tumor underscores the key importance of morphological research in determining the degree of anaplasia of nerve tumors.

  • Open Access

    Results of research work Russian society of oncomammologists “The use of artificial intelligence for early detection of breast cancer”

    by V. I. Pavlova, Yu. A. Belaya, A. Yu. Vorontsov, A. A. Prishchepov, S. M. Knyazev, A. A. Mikhaylov, A. V. Kovaleva, E. G. Arevshatyan, R. M. Paltuev, A. V. Chernaya, et al.

    Breast cancer is the most common cancer in women and one of the leading causes of death from cancer in Russia and most countries of the world. In countries with mammographic screening, there is a decrease in mortality from breast cancer. Introduction of mammographic image evaluation platforms into radiologist practice based on the work of artificial intelligence it allows not only to increase the coverage of the female population, but also to reduce the cost of screening, but it also increases the sensitivity and specificity of mammography as a method of breast cancer screening.The article presents the results of a study on the evaluation of mammographic images in women who have passed a preventive study using an artificial intelligence program.Within the framework of this project, mammographic images were analyzed using the service for viewing medical images “Celsus” in 8030 patients. The study assessed the age groups of 40-49 years, 50-59 years, 60 years and older. The average age of patients with suspected breast cancer was 54.8 years. Breast cancer was detected in 13 women (1.2 %), while the highest percentage of breast cancer was detected in the group with mammographic density D.